Literature DB >> 11605654

Pyrrolo[2,3-d]pyrimidine thymidylate synthase inhibitors: design and synthesis of one-carbon bridge derivatives.

K Aso1, Y Imai, K Yukishige, K Ootsu, H Akimoto.   

Abstract

A series of novel pyrrolo[2,3-d]pyrimidine derivatives was designed and synthesized as thymidylate synthase (TS) inhibitors. Molecular design was performed on the human TS complex model built on the basis of the reported structure of TS-deoxyuridinemonophosphate (dUMP)-CB3717 ternary complex. From a docking study, we expected that a one-carbon bridge between pyrrolo[2,3-d]pyrimidine and an aromatic ring was suitable. Moreover, we found that the bridge carbon could be replaced with an alkyl group to fill out the unoccupied space. Based on this design, we synthesized five pyrrolo[2,3-d]pyrimidine derivatives with one-carbon bridge and evaluated their TS inhibitory activities. All synthesized compounds inhibited TS more potently than compound 2 (LY231514), and the C8-ethyl analogue (7) showed a remarkable inhibitory activity against TS (IC50=0.017 microM).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11605654     DOI: 10.1248/cpb.49.1280

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  7 in total

1.  Understanding the structural basis of species selective, stereospecific inhibition for Cryptosporidium and human thymidylate synthase.

Authors:  Daniel J Czyzyk; Margarita Valhondo; William L Jorgensen; Karen S Anderson
Journal:  FEBS Lett       Date:  2019-06-18       Impact factor: 4.124

2.  Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductase.

Authors:  Vidya P Kumar; Jose A Cisneros; Kathleen M Frey; Alejandro Castellanos-Gonzalez; Yiqiang Wang; Aleem Gangjee; A Clinton White; William L Jorgensen; Karen S Anderson
Journal:  Bioorg Med Chem Lett       Date:  2014-07-24       Impact factor: 2.823

3.  Synthesis and evaluation of a classical 2,4-diamino-5-substituted-furo[2,3-d]pyrimidine and a 2-amino-4-oxo-6-substituted-pyrrolo[2,3-d]pyrimidine as antifolates.

Authors:  Aleem Gangjee; Jie Yang; John J McGuire; Roy L Kisliuk
Journal:  Bioorg Med Chem       Date:  2006-09-20       Impact factor: 3.641

4.  Discovery of 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as dual-acting inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis: implications of inhibiting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase to ampk activation and antitumor activity.

Authors:  Shermaine Mitchell-Ryan; Yiqiang Wang; Larry H Matherly; Aleem Gangjee; Sudhir Raghavan; Manasa Punaha Ravindra; Eric Hales; Steven Orr; Christina Cherian; Zhanjun Hou
Journal:  J Med Chem       Date:  2013-12-11       Impact factor: 7.446

5.  Novel 5-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase and as potential antitumor agents.

Authors:  Yiqiang Wang; Shermaine Mitchell-Ryan; Sudhir Raghavan; Christina George; Steven Orr; Zhanjun Hou; Larry H Matherly; Aleem Gangjee
Journal:  J Med Chem       Date:  2015-02-02       Impact factor: 7.446

6.  Substituted pyrrolo[2,3-d]pyrimidines as Cryptosporidium hominis thymidylate synthase inhibitors.

Authors:  Vidya P Kumar; Kathleen M Frey; Yiqiang Wang; Hitesh K Jain; Aleem Gangjee; Karen S Anderson
Journal:  Bioorg Med Chem Lett       Date:  2013-07-24       Impact factor: 2.823

7.  Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors.

Authors:  D J Czyzyk; M Valhondo; L Deiana; J Tirado-Rives; W L Jorgensen; K S Anderson
Journal:  Eur J Med Chem       Date:  2019-09-04       Impact factor: 6.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.